z-logo
Premium
Adrenergic regulation of a key cardiac potassium channel can contribute to atrial fibrillation: evidence from an I Ks transgenic mouse
Author(s) -
Sampson Kevin J.,
Terrenoire Cecile,
Cervantes Daniel O.,
Kaba Riyaz A.,
Peters Nicholas S.,
Kass Robert S.
Publication year - 2008
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jphysiol.2007.141333
Subject(s) - atrial fibrillation , potassium channel , adrenergic , genetically modified mouse , medicine , transgene , cardiology , key (lock) , potassium , endocrinology , microbiology and biotechnology , biology , chemistry , receptor , gene , genetics , ecology , organic chemistry
Inherited gain‐of‐function mutations of genes coding for subunits of the heart slow potassium (I Ks ) channel can cause familial atrial fibrillation (AF). Here we consider a potentially more prevalent mechanism and hypothesize that β‐adrenergic receptor (β‐AR)‐mediated regulation of the I Ks channel, a natural gain‐of‐function pathway, can also lead to AF. Using a transgenic I Ks channel mouse model, we studied the role of the channel and its regulation by β‐AR stimulation on atrial arrhythmias. In vivo administration of isoprenaline (isoproterenol) predisposes I Ks channel transgenic mice but not wild‐type (WT) littermates that lack I Ks to prolonged atrial arrhythmias. Patch‐clamp analysis demonstrated expression and isoprenaline‐mediated regulation of I Ks in atrial myocytes from transgenic but not WT littermates. Furthermore, computational modelling revealed that β‐AR stimulation‐dependent accumulation of open I Ks channels accounts for the pro‐arrhythmic substrate. Our results provide evidence that β‐AR‐regulated I Ks channels can play a role in AF and imply that specific I Ks deregulation, perhaps through disruption of the I Ks macromolecular complex necessary for β‐AR‐mediated I Ks channel regulation, may be a novel therapeutic strategy for treating this most common arrhythmia.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom